QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

SomaLogic Stock Price, News & Analysis (NASDAQ:SLGC)

$2.78
-0.05 (-1.77%)
(As of 12/4/2023 ET)
Compare
Today's Range
$2.73
$2.91
50-Day Range
$1.76
$2.83
52-Week Range
$1.73
$3.79
Volume
1.70 million shs
Average Volume
1.16 million shs
Market Capitalization
$522.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.26

SomaLogic MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
53.2% Upside
$4.26 Price Target
Short Interest
Healthy
4.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$79,754 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.59) to ($0.49) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Business Services Sector

99th out of 301 stocks

Commercial Physical Research Industry

6th out of 12 stocks


SLGC stock logo

About SomaLogic Stock (NASDAQ:SLGC)

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

SLGC Stock Price History

SLGC Stock News Headlines

SomaLogic Inc Class A
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Recap: SomaLogic Q3 Earnings
SomaLogic announces new SomaScan® 11K Platform
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
SomaLogic expands agreement with Novo Nordisk to 2025
More on SomaLogic
Why Shares of SomaLogic Are Up Tuesday
SomaLogic Reports Second Quarter 2023 Financial Results
See More Headlines
Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/26/2024

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:SLGC
Fax
N/A
Employees
451
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.26
High Stock Price Target
$7.00
Low Stock Price Target
$2.30
Potential Upside/Downside
+53.2%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-109,160,000.00
Net Margins
-159.54%
Pretax Margin
-159.08%

Debt

Sales & Book Value

Annual Sales
$97.67 million
Book Value
$3.00 per share

Miscellaneous

Free Float
160,049,000
Market Cap
$522.83 million
Optionable
Not Optionable
Beta
1.69
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Stephen A. Williams BS (Age 63)
    MB, Ph.D., Chief Medical Officer
    Comp: $648.03k
  • Mr. Adam Taich (Age 48)
    Interim CEO
  • Mr. Eliot M. Lurier CPA (Age 65)
    Interim Chief Financial Officer
  • Mr. Pi Zheng (Age 50)
    Interim Chief Accounting Officer
  • Dr. Jason Cleveland Ph.D.
    Chief Technology Officer
  • Dr. Nebojsa Janjic Ph.D. (Age 62)
    Chief Science Officer
  • Mr. Ruben Gutierrez J.D. (Age 48)
    General Counsel
  • Ms. Alison Marie Roelke (Age 48)
    Chief People Officer
  • Dr. Shane Bowen Ph.D.
    Chief Research & Development Officer














SLGC Stock Analysis - Frequently Asked Questions

Should I buy or sell SomaLogic stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SomaLogic in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SLGC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SLGC, but not buy additional shares or sell existing shares.
View SLGC analyst ratings
or view top-rated stocks.

What is SomaLogic's stock price target for 2024?

5 analysts have issued 1 year price targets for SomaLogic's stock. Their SLGC share price targets range from $2.30 to $7.00. On average, they expect the company's share price to reach $4.26 in the next year. This suggests a possible upside of 53.2% from the stock's current price.
View analysts price targets for SLGC
or view top-rated stocks among Wall Street analysts.

How have SLGC shares performed in 2023?

SomaLogic's stock was trading at $2.51 at the beginning of 2023. Since then, SLGC shares have increased by 10.8% and is now trading at $2.78.
View the best growth stocks for 2023 here
.

When is SomaLogic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024.
View our SLGC earnings forecast
.

How were SomaLogic's earnings last quarter?

SomaLogic, Inc. (NASDAQ:SLGC) released its earnings results on Wednesday, November, 8th. The company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.05. The business had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic had a negative trailing twelve-month return on equity of 24.72% and a negative net margin of 159.54%.

What ETF holds SomaLogic's stock ?

ARK Genomic Revolution ETF holds 13,104,112 shares of SLGC stock, representing 1.22% of its portfolio.

What guidance has SomaLogic issued on next quarter's earnings?

SomaLogic updated its FY 2023 earnings guidance on Friday, October, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $80.00 million-$84.00 million, compared to the consensus revenue estimate of $81.94 million.

Who are SomaLogic's major shareholders?

SomaLogic's stock is owned by a number of retail and institutional investors. Top institutional investors include ARK Investment Management LLC (6.90%), Sumitomo Mitsui Trust Holdings Inc. (4.66%), Barclays PLC (1.38%), Kent Lake Capital LLC (1.03%), Charles Schwab Investment Management Inc. (0.65%) and Zweig DiMenna Associates LLC (0.33%). Insiders that own company stock include Adam Taich, Alison Marie Roelke and Ruben Gutierrez.
View institutional ownership trends
.

How do I buy shares of SomaLogic?

Shares of SLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SLGC) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -